PHARMACOGENOMIC INFORMATION IN OFFICIAL DRUG LABELLING

• At: AbuDhabi (United Arab Emirates) (2019)
• Type: Poster
• Poster code: POS-RSC-009
• By: AZZOPARDI, Yasmine (University of Malta, Faculty of Medicine and Surgery, Malta)
• Co-author(s): Yasmine Azzopardi: Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
  Francesca Wirth: Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
  Liberato Camilleri: Department of Statistics and Operations Research, Faculty of Science, University of Malta, Msida, Malta
  Anthony Serracino-Inglott: Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta;, Malta Medicines Authority, Malta Life Sciences Park, San Gwann, Malta
  Lilian M Azzopardi: Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
  
• Abstract:

  Background

  Harmonisation of pharmacogenomic (PGx) information in drug labelling between regulatory bodies facilitates clinical implementation of PGx.

  Methods

  The FDA drug label and EMA Summary of Product Characteristics (SmPC) of 70 drugs with PGx implications in four disease categories (malignancy and immunosuppression, infections, cardiovascular

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login